Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,071,498

« Back to Dashboard

Summary for Patent: 6,071,498

Title: Inhaler for powdered medicaments
Abstract:Pharmaceutical powder cartridge for powder inhalers for receiving a medicament depot for a large number of pharmaceutical powder doses, having an integrated metering device which comprises at least one metering cavity for receiving a predetermined quantity of a pharmaceutical powder, the integrated metering device being capable of being moved at least out of a filling position into an emptying position approximately transversely with respect to the flow direction of the pharmaceutical powder, and an inhaler for powdered medicaments, in which inhaler the medicament can be received by a patient by means of an air stream and which has a receptacle for such a pharmaceutical powder cartridge.
Inventor(s): Narodylo; Andre (Linsengericht, DE), Gottenauer; Wolfgang (Bruchkobel, DE), Goede; Joachim (Hanau, DE), Lerk; Coenraad (Peize, NL), De Boer; Anne H. (Drachten, NL)
Assignee: ASTA Medica Aktiengesellschaft (Dresden, DE)
Application Number:09/113,652
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 6,071,498

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 22 416Jun 21, 1995
Germany195 22 415Jun 21, 1995

International Patent Family for Patent: 6,071,498

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina002534► Subscribe
Austria209518► Subscribe
Australia6221196► Subscribe
Australia719449► Subscribe
Brazil9608997► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus